April 12, 2018 The University of Kansas Cancer Center will present preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), an anti-cancer agent currently in Phase I clinical trials, at the American Association for Cancer Research (AACR) 2018 Annual Meeting in Chicago. Ciclopirox Prodrug was discovered by researchers at The University of Kansas Cancer Center and KU’s Institute […]Continue Reading ...
Credit: CC0 Public Domain The possible link between physicians’ opioid prescription patterns and subsequent abuse has occupied the attention of a nation in the throes of an opioid crisis looking for ways to stem what experts have dubbed an epidemic. Most clinical efforts have focused on minimizing risk through dosage management, but a new study […]Continue Reading ...
By Dr Ananya Mandal, MDMarch 2, 2018 According to a new study, what we suspected is true – the nose does look too big in a selfie and it is not imagination! The study says that the nose looks up to 30 percent bigger in a selfie or a self-photograph. The results of the study […]Continue Reading ...
March 1, 2018 Scientists on the Florida campus of The Scripps Research Institute (TSRI) have discovered a new target for treating major depressive disorder, a disease that affects more than 16 million American adults. Their research shows that individuals with high levels of an enigmatic receptor called GPR158 may be more susceptible to depression following […]Continue Reading ...
Action Points PCI revascularization instead of CABG among diabetic patients with low left ventricular ejection fraction (LVEF) led to a >60% relative reduction and 16% absolute reduction in survival over 5 years, according to Canadian observational data on 2,837 patients. Note that PCI recipients were at a disadvantage compared to peers who received CABG in […]Continue Reading ...
February 28, 2018 Bacteria from humans and animals continue to show resistance to antimicrobials, according to a new report published today by the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC). The report highlights some emerging issues and confirms antimicrobial resistance (AMR) as one of the biggest threats […]Continue Reading ...
Two years ago, when Johns Hopkins medical student Davis Rogers read reports detailing the prevalence of depression among medical students and residents, he resolved to find a way to help promote mental health among his peers. When he was invited to join the Task Force on Student Mental Health and Well-Being—a cross-divisional group of Hopkins […]Continue Reading ...
By Dr Ananya Mandal, MDFebruary 27, 2018 According to a new study, the rates of obesity among kids in the United States did not decrease for any age group and continued to rise among many subgroups. This new study has shown that overall the numbers have not fallen between 1999 and 2016 as hoped for. […]Continue Reading ...
In the operating room Brown monitors patient EEG readings in real time to adjust anesthetic dosing. Often he can safely and comfortably give less than the supposedly needed dose. Credit: Len Rubinstein/MIT It’s intuitive that anesthesia operates in the brain, but the standard protocol among anesthesiologists when monitoring and dosing patients during surgery is to […]Continue Reading ...
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Trump Administration May Expand State Mental Health Treatment Ways to allow states to expand inpatient mental health treatment using Medicaid funds are being explored by the Trump administration in the wake of the mass shooting at a school […]Continue Reading ...
Gilead’s Biktarvy Cleared for Use in HIV-1 Infection In February, the FDA approved Gilead’s Biktarvy (bictegravir, emtricitabine and tenofovir alafenamide, or BIC/FTC/TAF), a combination, once-daily, oral treatment for HIV-1 infection in adults. Biktarvy is used for the treatment of two HIV groups: either those who have no antiretroviral treatment history or those who are virologically […]Continue Reading ...
Is your patient’s refrigerator the problem with the inefficacy of biologic therapies? Biologics agents such as adalimumab (Humira), golimumab (Simponi), and ustekinumab (Stelara) should be stored at a temperature of 2-8°C (35.6-46.4°F). Several studies have identified a prevalent problem of unacceptable refrigeration storage of biologics used to treat immune-mediated inflammatory disorders (IMID), such as rheumatoid […]Continue Reading ...
February 28, 2018 By turning down the activity of a specific RNA molecule researchers at Sahlgrenska Academy, Sweden, have cured lung tumors in mice by 40-50 percent. The results, published in Nature Communications, represent the tip of the iceberg in an extensive research project in which 633 new biomarkers for 14 types of cancer have […]Continue Reading ...
February 28, 2018 When women take the common diabetes medication metformin during pregnancy, it may put their children at increased risk of having obesity or overweight. A growing number of pregnant women are taking metformin to treat gestational diabetes or a condition called polycystic ovary syndrome (PCOS). PCOS is a common cause of infertility and […]Continue Reading ...
February 26, 2018 Despite reports in recent years suggesting childhood obesity could be reaching a plateau in some groups, the big picture on obesity rates for children ages 2 to 19 remains unfavorable. Three decades of rising childhood obesity continued their upward trend in 2016 according to a new analysis from Duke Health researchers. The […]Continue Reading ...
- Researchers identify molecule to fight myotubular myopathy
- Immune cells trigger OCD-like behaviour in multiple sclerosis, study finds
- Scientists equip new virus that kills carcinoma cells with protein
- Protein in cell membranes of sperm plays key role in finding their way to eggs
- Parents who decline flu vaccination for their child may be exposed to limited information
- Mirati Presents Data From Ongoing Phase 2 Clinical Trial Of Mocetinostat In Combination With Durvalumab At The SITC 33rd Annual Meeting
- FDA warns of common diabetes meds’ link to dangerous genital infection
- New methods for preserving shoulder function, quality of life in breast cancer patients
- Surprising discovery about BH4 may rekindle interest in once-promising pathway
- Nabriva Therapeutics Completes Submission of New Drug Application to U.S. Food and Drug Administration for Intravenous Contepo to Treat Complicated Urinary Tract Infections
- Beating breast cancer only to die of opioid use – a sad Appalachian story
- Workplace bullying or violence linked to higher risk of cardiovascular problems
- Changes in Risk Indicators of MetS Severity Tied to T2DM Risk
- ‘Game-changing’ skin sensor could improve life for a million hydrocephalus patients
- Alcohol ads on social media sites with pro-drinking comments increase desire to drink
- Neural networks could replace marker genes in RNA sequencing
- Obese adolescents feel less food enjoyment than those with normal weight, study reveals
- Goodbye ‘Gluten-Free’? Celiac Disease Vaccine May Make It Possible
- Skin ages when the main cells in the dermis lose their identity and function
- Rainforest vine compound makes pancreatic cancer cells susceptible to nutrient starvation